1
GOEIJ Bart de, BRINK Edward N van den, HAIJ Simone, RIEDL Thilo, HOET René, BAADSGAARD Ole, SATIJN David, WINKEL Jan van de, PARREN Paul: Anticorps monoclonaux contre lépitope de her2, Monoclonal antibodies against her2 epitope. Genmab, GOEIJ Bart de, BRINK Edward N van den, HAIJ Simone, RIEDL Thilo, HOET René, BAADSGAARD Ole, SATIJN David, WINKEL Jan van de, PARREN Paul, December 1, 2011: WO/2011/147982 (6 worldwide citation)

Isolated monoclonal antibodies which bind to human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed ...


2
Bart De Goeij, Edward Norbert Van Den Brink, Simone De Haij, Thilo Riedl, Rene Hoet, Ole Baadsgaard, David Satijn, Jan Van De Winkel, Paul Parren: Monoclonal antibodies against HER2 epitope. GENMAB, Nelson Mullins Riley & Scarborough, Jane E Remillard Esq, Christopher L Frank, July 25, 2017: US09714294

Isolated monoclonal antibodies which bind to human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed ...


3
Natalya D Bodyak, Michael J DeVit, Eric M Krauland, Timothy B Lowinger, Peter U Park, Bianka Prinz, Aleksandr V Yurkovetskiy: Monoclonal antibodies against HER2 epitope and methods of use thereof. Mersana Therapeutics, Cooley, Heidi A Erlacher, Jennifer A Karmakis, August 22, 2017: US09738720

This invention provides fully human monoclonal antibodies that recognize HER2. The invention further provides methods of using such monoclonal antibodies in a variety of therapeutic, diagnostic, and prophylactic indications.


4

5
MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE. GENMAB, July 4, 2013: US20130171148-A1

Isolated monoclonal antibodies which bind to human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and therapeutic and diagnostic methods for using the antibodies are also disclosed ...


6
Monoclonal Antibodies Against HER2 Epitope and Methods of Use Thereof. March 9, 2017: US20170066830-A1

This invention provides fully human monoclonal antibodies that recognize HER2. The invention further provides methods of using such monoclonal antibodies in a variety of therapeutic, diagnostic, and prophylactic indications.